- The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

DJ Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 20-Sep-2023 / 12:41 GMT/BST=----------------------------------------------------------------------------------------------------------------------

The Vanguard Group, Inc. Form 8.3 20-Sep-2023 / 12:41 GMT/BST =---------------------------------------------------------------------------------------------------------------------- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code 1. KEY INFORMATION Full name of discloser: The Vanguard Group, Inc.

Details of any open stock-settled derivative positions , or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 .Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

Class of relevant Product description Exercising/ exercised security against Number of securities Exercise price per unit e.g. call option Other dealings Is a Supplemental Form 8 attached? No Date of disclosure: 20 September 2023 Contact name: Shawn Acker Telephone number*: 001-610-669-6713 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

FN_Nachrichten /  🏆 88. in DE

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

- The Vanguard Group, Inc.: Network International Holdings plcDJ Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc 19-Sep-2023 / 13:48
続きを読む »

- The Vanguard Group, Inc.: Dechra Pharmaceuticals plcDJ Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 19-Sep-2023 / 13:50 GMT/BST=----------------------------------------------------------------------------------------------------------------------
続きを読む »

- The Vanguard Group, Inc.: Horizon Therapeutics plcDJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc The Vanguard Group, Inc. ( IRSH) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc 19-Sep-2023 / 14:46 GMT/BST=----------------------------------------------------------------------------------------------------------------------
続きを読む »

Telefonica Deutschland Sell (Goldman Sachs Group Inc.) 19.09.2023 | AnalyseTelefonica Deutschland Sell (Goldman Sachs Group Inc.) 19.09.2023 | Analyse | finanzen.net
続きを読む »

MDAX-Papier KION GROUP-Aktie: So viel hätte eine frühe Investition in KION GROUP gekostetVor Jahren in KION GROUP eingestiegen: So viel hätten Investoren verloren.
続きを読む »

Ensurge Micropower Inc.: Ensurge Micropower sichert sich neuen Vertrag mit führendem Anbieter von tragbaren GerätenSAN JOSE, Kalifornien, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Nach jahrelanger Entwicklung, einzigartiger Technik und Tests sieht Ensurge Micropower (OSE: ENSU und OTCQB: ENMPY) einen Durchbruch und festigt
続きを読む »